Botanical species · safety record

Myrica cerifera

The EFSA Compendium of Botanicals holds 2 constituent measurements for Myrica cerifera. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Myrica cerifera L.

2Constituent measurements

0Safety records

2Cited sources

36Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 36 licensed products naming Myrica cerifera as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Bark
Root
Root bark

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Leaves	Essential oil	30.7 Percent	GC-MS	Resolve DOI
Tannins	Bark	Solvent extraction	—	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Schmidt, J.M., Noletto, J.A., Vogler, B., Setzer, W.N. Abaco bush medicine: Chemical composition of the essential oils of four aromatic medicinal plants from Abaco Island, Bahamas. Journal of herbs, spices and medicinal plants, 2006, vol. 12, no. 3, p. 43-65. DOI
Youngken, Heber W. Studies of the bark of Myrica cerifera, Linne. Journal of the American Pharmaceutical Association, None.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature